top of page
38. 2024 AI賦能共創智慧醫院智慧醫材業者媒合交流會
2024 AI Empowerment Co-Creation Smart Hospital, Smart Medical Device Industry Matchmaking and
Exchange Conference
2024-05-02
TFDA.jpg
TFDA.jpg
TFDA.jpg
TFDA.jpg
1/4
由食藥署與亞東醫院主辦,國科會協辦「2024 AI賦能共創智慧醫院,智慧醫材業者媒合交流會」,特別邀請醫華生技到場以「AI半導體液態腫瘤影像系統在循環腫瘤檢測上的突破與案例分享」為題,分享AI技術所帶動的智慧醫療情境及商機;此外,國科會提供參展廠商名單 ,經由食藥署篩選審核後,醫華生技獲得現場參展的機會,並且與遠傳電信、鴻海科技、醫守生技、宇康生科等廠商進行交流與探討,期待未來更多的合作與貢獻。
TFDA and Far Eastern Memorial Hospital, in collaboration with NSTC, hosted the "2024 AI Empowerment Co-Creation Smart Hospital, Smart Medical Device Industry Matchmaking and Exchange Conference." CytoAurora was specifically invited to present its groundbreaking NANO CAST technology for detecting circulating tumor cells (CTC), shedding light on the transformative impact of AI in healthcare and the promising business prospects it offers. NSTC facilitated the event by providing a comprehensive list of exhibitors. Following a rigorous screening process by TFDA, CytoAurora secured a spot for on-site exhibition, allowing us to interact with industry leaders such as Fetnet, Foxconn, AESOP, and APrevent. We eagerly anticipate forging new partnerships and making meaningful contributions in the future.
bottom of page